Unusual clinical manifestation of pheochromocytoma in a MEN2A patient (original) (raw)

2002, Journal of Endocrinological Investigation

Abstract

A case of unusual clinical manifestation of pheochromocytoma in a type 2A multiple endocrine neoplasia (MEN2A) patient is presented. A 27-year-old man affected by MEN2A syndrome, complaining of anxiety and depression. was admitted in our Division. Past medical history included a total thyroidectomy for medullary carcinoma in 1985, and left adrenalectomy for pheochromocytoma in 1994. Blood pressure was 130/ 85 mmHg without orthostatic hypotension and pulse rate was 72 beats/min. Laboratory data revealed thyroid hormones and carcinoembryonic antigen (CEA) in the normal range and high basal serum calcitonin levels (158 pg/ml). Plasma catecholamines and vanillylmandelic acid resulted in normal levels but epinephrine/norepinephrine ratio was elevated (0.65). The glucagon stimulation test showed positive clinical and biochemical response. MagnetiC resonance imaging (MRI) and meta-iodobenzylguanidine (MIBG) scintiscan con

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (28)

  1. Bouloux P.G., Fakeeh M. Investigation of pheochromocytoma. Clin. Endocrinol. (Oxf.) 1995, 43: 657-664.
  2. Gagel R.F., Tashjan AH ., Cummings T., Papathana- sopoulos N. , Kaplan M. , De Le llis R.A , Wolfe H.J. , Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A
  3. N . Engl. J. Med . 1988, 318: 478-484.
  4. Gagner M. Laparoscopic adrenalectomy. Surg. Clin. North Am. 1996, 76: 3, 523-537. 56 Unusual manifestation of pheochromocytoma
  5. Filipponi S., Guerrieri M ., Arnaldi G ., Giovagnetti M. , Masini AM. , Lezoche E. , Mantero F. Laparoscopic adrenalectomy: a report on 50 oper- ations.
  6. Eur. J. Endocrinol. 1998, 138: 548-553.
  7. Bonnin F. , Schlumberger M. , Gardet P. , Tenembaum F. , Lumbroso J. , Lec lere J. , Comoy E. , M eg nigbeto A , Travagli J.P., Parmentier C. Screening for adrenal medullary disease in patients with med ullary thyroid carcinoma. J. Endocrinol. Invest. 1994, 17: 253-257.
  8. Evans D.B., Lee J.E., Merrell R.C., Hickey R.C. Adre nal medullary disease in multipl e e ndocrin e neoplasia type 2. Appropriate management. Endocrinol. Metab. Din. North Am. 1994, 23: 167-176.
  9. Grossman E .. Goldstein D.S .. Hoffman A, Keiser H.R. Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 1991, 17: 733-741 .
  10. EI-Matri A , Slim R., Smerli S., Ayed H.B. Pheochromocytome avec troubles psychiatriques. Un cas. Nouv. Presse Med . 1978,7: 1467-1470.
  11. Goldenberg M . Pheochromocytoma and essential hypertensive vas- cular disease. Arch . Intern . Med . 1950, 86: 823-836.
  12. Aquilar-Parada E., Rivadeneyra J ., Torres-Leon AG ., Serrano P.A Pseudopheochromocytoma. JAMA1971,218:884-885 .
  13. Lefebvre H., Noblet C., Moore N ., Wolf L.M . Pseudo-pheochromocytoma after multiple drug in- teractions involving the selective monoamine oxi- dase inhibitor selegiline. Clin . Endocrinol. (Oxf.) 1995, 42: 95-98 .
  14. Duarte J ., Sempere A.P ., Cabezas C. , Calvo T ., Claveria L.E. Pseudo-pheoc hromocytoma in a patient with Par- kinson's disease. Ann. Pharmacother. 1996, 30: 546.
  15. Bravo E.L. Evolving concepts in the pathophysiology, diagno- sis and treatment of pheochromocytoma . Endocr. Rev. 1994, 15: 356-368.
  16. Chakravorty S.G. , De Souza c.J., Doongaji D.R. A psychiatric evaluation of referred cancer and med- ical patients: a comparative study . Indian J. Cancer 1993, 30: 55-60.
  17. Berard R.M. , Boermeester F. Psychiatric syntomatology in adolescents with cancer. Pediatr. Hemato l. Oncol. 1998, 15: 211-214 .
  18. Holland J.C. , Mastrovito R. Psychologic adaptation to brest cancer . Cancer 1980, 46 (Suppl. 4): 1045-1052.
  19. Laparoscopic removal of pheochromocytoma. Why? When? And Who? (Reflections on one case report) .
  20. Surg. Endosc. 1995, 9: 431-436.
  21. Moley J .F. Medullary thyroid cancer. Surg. Clin. North Am. 1995, 75: 405-420.
  22. Murat A., GETC (Group d'Etude des Tumeurs a Calcitonine). Delection des lesions residuelles et des metastases du cancer medulla ire de la thyroide . Ann. Endocrinol. (Paris) 1996, 57: 27-32.
  23. Tisell L.E., Dilley W.G., Wells SA Progression of postoperative residual medullary thy- roid carcinoma as monitored by plasma calcitonin levels. Surgery 1996, 119: 34-39.
  24. Calender A., Giraud 5., Schuffenecker I., Lenoir G .M ., Gaudray P., Courseaux A., Porchet N ., Aubert J.P., Zhang C.x. 57 Genetic testing in presymptomatic diagnosis of mul- tiple endocrine neoplasia. Horm. Res. 1997, 47: 199-210.
  25. Eisenhofer G., Lenders J.W., Linehan W.M., Walther M.M., Goldstein 0.5., Keiser H.R. Plasma normetanephrine and metanephrine for de- tecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N. Engl. J . Med . 1999, 340: 1872-1879.
  26. Gokce 0., Gokce C., Gunel 5., Arisoy 5., Arisoy E., Huseyinoglu K., Kismet K., Ucar O. Pheochromocitoma presenting with headache, pan- ic attacks and jaundice in a child. Headache 1991, 31: 473-475.
  27. Carre A . Panic attack: viewpoint of the internist. Encephale 1996, 5: 11-12.
  28. Lambert M.T. Pheochromocitoma presenting as exacerbation of post traumatic stress disorder symptomology. Int. J. PSYChiatry Med. 1992, 22: 265-268.